Twist Bioscience Corporation provided revenue guidance for the second quarter of fiscal year 2024. Total revenue of approximately $70 million to $71 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.2 USD | +4.35% | +34.96% | +17.20% |
05-03 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
05-03 | Sector Update: Health Care Stocks Mixed in Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.20% | 2.41B | |
-2.77% | 88.91B | |
+2.76% | 41.25B | |
-13.92% | 31.99B | |
+50.51% | 24.73B | |
-15.25% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.80% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- TWST Stock
- News Twist Bioscience Corporation
- Twist Bioscience Corporation Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024